Definitive Contract 75N95022C00041

Award Date 9/30/22
Potential Completion Date 9/29/27
Potential Value $9.2M
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

This is a $9,236,720 cost-plus-fixed-fee contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS) to The Emmes Company LLC, a global clinical research organization. The contract, titled "NINDS CENTER FOR CLINICAL TRIAL RESOURCES", has a period of performance through September 2027 and supports NINDS' clinical research program. The work includes quality assurance/control monitoring, statistical analysis, data management, and development of common data elements. This contract is not set aside for any specific business type.

The Emmes Company LLC is an experienced federal contractor, holding numerous prime and subcontracts with NIH institutes, including a $545 million Indefinite Delivery Vehicle (IDV) with the National Institute of Allergy and Infectious Diseases. This new NINDS award demonstrates Emmes' broad capabilities in supporting complex biomedical research initiatives across areas like infectious diseases, oncology, and rare disorders.

Generated 12/3/24, 10:05 AM